[250 Pages Report] The global ultrasound-guided breast biopsy market is expected to reach US$ 1,090 Mn in 2032, exhibiting a CAGR of 8% during the forecast period. Ultrasound-guided biopsy market is currently valued at US$ 720 Mn in 2022. Rising incidence of breast cancer cases and increasing awareness about early diagnosis of breast cancer will push sales in the market over the forecast period.
| Report Attribute | Details |
|---|---|
| Ultrasound-Guided Breast Biopsy Market Size (2022) | US$ 720 million |
| Ultrasound-Guided Breast Biopsy Market Size (2032) | US$ 1,090 million |
| Ultrasound-Guided Breast Biopsy Market Projected Growth Rate (2022-2032) | 8% CAGR |
According to a 2021 report by WHO, there were 2.3 million women diagnosed with breast cancer and 685,000 deaths, globally, in the year 2020. In 2020, 7.8 million women were living with breast cancer, making it world’s most prevalent cancer.
Breast cancer forms either with the breast tissue which is made up of glands for milk production known as lobules or begins in the ducts. These abnormalities or lumps in the breasts are generally detected with mammography, physical examinations, or other imaging techniques such as ultrasound-guided breast biopsy.
In an ultrasound-guided breast biopsy, radiologists use ultrasound imaging as a guide to inspect the site of the abnormal cell growth. A breast biopsy with the aid of ultrasound is mostly performed when an abnormality such as a distortion of the breast tissue or a suspicious mass of solid is felt around the breast.
High rate of mortality and increasing incidence of breast cancer will underpin the adoption of ultrasound-guided breast biopsy over the assessment period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Ultrasound-guided breast biopsy is comparatively less invasive than other surgical biopsies, it leaves little scarring and can be performed in a limited time frame. These factors, combined together, will increase the adoption rate of ultrasound-guided breast biopsy.
In addition to this, ultrasound-guided breast biopsy does not carry ionizing radiation and provides faster results. It is also less expensive and has shorter recovery period. On the back of these factors, demand in the market is projected to increase at a considerable pace over the forecast period.
Ultrasound-guided breast biopsy also has certain aspects that impede sales in the market. The ultrasound-guided breast biopsy is known to carry a risk of bleeding that forms hematoma because of which consumers might reject this method of biopsy. This in turn hampers the growth in the ultrasound-guided breast biopsy market.
Furthermore, other factors such as discomfort experienced by patients during biopsy and the cost of an ultrasound machine might also impede the growth in ultrasound-guided breast biopsy market over the forecast period.
Principal Consultant
The American Cancer Society’s estimates for the year 2022 states that there will be 287,850 new cases of breast cancer, with 43,250 deaths. This rising prevalence of breast cancer along with an increasingly alert population may increase the demand for ultrasound-guided breast biopsy in North America.
Thus, ultrasound-guided breast biopsy market in North America is expected to exhibit a significant growth rate for the forecast period. Advancing technologies, high investments in the healthcare sector, and increasing production of new and improved imaging technologies will augment sales in the ultrasound-guided breast biopsy market in North America.
Increasing awareness regarding early diagnosis and treatment of breast cancer among individuals across Asia Pacific is expected to create opportunities for growth in the market. Owing to rising amount of campaigns about breast cancer, majority of the population is aware about diagnosis and treatment methods for breast cancer. This is expected to boost the Asia Pacific ultrasound-guided breast biopsy market over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Leading players operating in the global ultrasound-guided breast biopsy market include Hologic, Inc., Medsurge Ind Private Limited among others.
Key companies in the market are engaged in developing their portfolio of breast biopsy products and accessories. The focus is also on contracts and partnerships to launch insight driven products, product commercialization and pipeline development in order to strengthen market position.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2021 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
North America is set to lead ultrasound-guided breast biopsy market growth over the forecast period.
Hologic Inc. and Medsurge Ind Private Limited are the two key players in the ultrasound-guided breast biopsy market.
The global ultrasound-guided breast biopsy market is estimated to reach US$ 720 Mn in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Procedure, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Procedure, 2022-2032
5.3.1. Fine Needle Aspiration (FNA)
5.3.2. Core Needle (CN)
5.3.3. Vacuum-assisted Device (VAD)
5.3.4. Wire Localization
5.4. Y-o-Y Growth Trend Analysis By Procedure, 2017-2021
5.5. Absolute $ Opportunity Analysis By Procedure, 2022-2032
6. Global Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostics Laboratories
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
7. Global Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Procedure
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Procedure
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Procedure
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Procedure
9.3.3. By End User
9.4. Key Takeaways
10. Europe Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Russia
10.2.1.6. BENELUX
10.2.1.7. Rest of Europe
10.2.2. By Procedure
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Procedure
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Rest of Asia Pacific
11.2.2. By Procedure
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Procedure
11.3.3. By End User
11.4. Key Takeaways
12. Middle East and Africa Ultrasound-Guided Breast Biopsy Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Turkey
12.2.1.4. Rest of Middle East and Africa
12.2.2. By Procedure
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Procedure
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Ultrasound-Guided Breast Biopsy Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Procedure
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Procedure
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Procedure
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Procedure
13.4.2.2. By End User
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Procedure
13.5.2.2. By End User
13.6. Italy
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Procedure
13.6.2.2. By End User
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Procedure
13.7.2.2. By End User
13.8. U.K.
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Procedure
13.8.2.2. By End User
13.9. Russia
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Procedure
13.9.2.2. By End User
13.10. BENELUX
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Procedure
13.10.2.2. By End User
13.11. China
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Procedure
13.11.2.2. By End User
13.12. Japan
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Procedure
13.12.2.2. By End User
13.13. South Korea
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Procedure
13.13.2.2. By End User
13.14. GCC Countries
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Procedure
13.14.2.2. By End User
13.15. South Africa
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Procedure
13.15.2.2. By End User
13.16. Turkey
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Procedure
13.16.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Procedure
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Hologic
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Medsurge
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Ethicon Endo Surgery
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Galini
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Leica Biosystems
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Becton and Dickinson Company
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Cook Medical Incorporated
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Argon Medical Devices
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Ultrasound-Guided Breast Biopsy Market
